Global ePRO, E-Patient Diaries and eCOA Strategic Business Report 2024: Market to Reach $4.7 Billion by 2030 – Rise in Clinical Trials Drives Demand –

DUBLIN–(BUSINESS WIRE)–The “ePRO, E-Patient Diaries and eCOA – Global Strategic Business Report” report has been added to’s offering.

Global ePRO, E-Patient Diaries and eCOA Market to Reach $4.7 Billion by 2030

The global market for ePRO, E-Patient Diaries and eCOA estimated at US$1.6 Billion in the year 2022, is projected to reach a revised size of US$4.7 Billion by 2030, growing at a CAGR of 14.7% over the analysis period 2022-2030.

eClinical Outcome Assessments (eCOAs), one of the segments analyzed in the report, is projected to record a 14.9% CAGR and reach US$1.4 Billion by the end of the analysis period. Growth in the Epatient Reported Outcomes (epros) segment is estimated at 16.4% CAGR for the next 8-year period.

The U.S. Market is Estimated at $561.4 Million, While China is Forecast to Grow at 17.5% CAGR

The ePRO, E-Patient Diaries and eCOA market in the U.S. is estimated at US$561.4 Million in the year 2022. China, the world’s second largest economy, is forecast to reach a projected market size of US$604.6 Million by the year 2030 trailing a CAGR of 17.5% over the analysis period 2022 to 2030. Among the other noteworthy geographic markets are Japan and Canada, each forecast to grow at 12.1% and 14% respectively over the 2022-2030 period. Within Europe, Germany is forecast to grow at approximately 13.3% CAGR.

Key Attributes:

Report Attribute

No. of Pages

Forecast Period
2022 – 2030

Estimated Market Value (USD) in 2022
$1.6 Billion

Forecasted Market Value (USD) by 2030
$4.7 Billion

Compound Annual Growth Rate

Regions Covered


Pivotal Role of eCOA, ePRO and Patient Engagement in Transforming Patient Centricity

An Introduction to ePRO, E-Patient Diaries and eCOA

Pandemic Jolt Brings Strategic & Lasting Changes to Healthcare Sector

COVID-19 Expedites Healthcare Ecosystem’s Evolution for Better Care & Cost Savings

Adoption of Telemedicine Services Accelerates Amidst the Pandemic

Pandemic Impact on eCOA, ePRO Market

COVID-19 Outbreak Compels Clinical Trials Industry to Move Towards ePRO

eCOA Solutions Help Address Hurdles Due to COVID-19 Pandemic

eCOA Playing a Part in Development of COVID-19 Vaccine

Global Market Outlook

eCOA: The Largest Category

ePRO Offers Tremendous Opportunities in Improving Healthcare System


Competitive Market Presence – Strong/Active/Niche for Players Worldwide in 2023 (E)

Recent Market Activity


Digitalization of Healthcare Services and Rising Importance of Electronic Data Capture Technologies to Fuel Market Growth

Patient Engagement Practices of the Future to be Shaped by Trends of Increased Use of Personal Devices and Passive Data

Key Patient Engagement Technology Trends and Innovations

eCOA & ePRO: A Powerful Duo Serving Clinical Trials with Electronic Data Collection

Rise in Clinical Trials Drives Need for ePRO, ePatient Diaries, and eCOA Solutions

COVID-19 Pandemic Triggers Technology Adoption in Clinical Trials

Trends in Clinical Trials Space to Influence Market Demand

Clinical Trials Increasingly Embraced Technology During COVID-19 Pandemic

Shift towards Decentralized/Virtual Clinical Trials to Boost Market Prospects

Decentralized Clinical Trials Driving Greater Demand for Patient-Centric Drug Development

Role of eCOA & ePRO in Enhancing Data Accuracy of Decentralized Clinical Trials

Growing Volumes of Data Generation in Decentralized Trials: A Challenge

Adoption of Digital Technologies in Contract Research Organizations Bodes Well for the Market

COVID-19 and Implications for Drug Development Regulations & Processes

Rise in Telemedicine Services Present Market Opportunities

Growing Adoption of Mobile Technologies and BYOD Trend in Healthcare Industry Boosts Market Prospects

Electronic Patient Record (ePRO) Solutions Emerge as Ideal Replacements for Paper-Based PRO systems

Moving over Paper Pains & Mastering the Art of Real-Time Data Collection with ePRO

Delivering Better Data: A Key Benefit of ePRO

Factors Ensuring Success of ePRO Implementations

ePatient Reported Outcomes (PROs) Gain Importance in Oncology Studies

Advances in ePRO Technologies Promise Better Clinical Decision Making in Healthcare Systems

Integrating AI into ePRO Improves the Efficiency of ePRO Data Collection and Assessment

Data Integrity, Security & Privacy: Key Priorities for ePRO Solutions

Electronic Clinical Outcome Assessment Solution (eCOA) Market: Poised for Growth

eCOA Grants The Best Route to Improve Data Quality & Patient Experience for Clinical Trials

Benefits Offered by eCOA Systems over the Paper-Based Systems in Trials

How to Successfully Implement eCOA Systems in Clinical Trials?

New Technologies & Approaches with Potential to Augment Statistical Prowess of eCOA

Technological Trends Transforming eCOA Solutions Market

Future Trends in eCOA Market: A Review

eCOA Proves Beneficial in Addressing Clinical Trial Challenges During COVID-19 Pandemic

UAT, Challenges and Embedded UAT for eCOAs

Benefits of BYOD for eCOAs

E-Patient Diaries: Significant Advantages over Paper Diaries to Drive Market

Major Benefits of ePatient Diary

eCOA & ePRO to Help Mental Health Research Shed the Taboo Status & Move Forward

Intriguing Perks of eCOA & ePRO for Mental Health Research

Increase in Healthcare Spending to Propel Demand

Increasing Burden of Chronic Diseases and Focus on Drug Development, Therapies and Vaccines Boost Market

Challenges Facing Companies Implementing eCOA, ePRO & Patient-Centric Clinical Trials


Dassault Systemes SE (3DS)

Almac Group

Clinical Ink, Inc.

Criterium, Inc.

Dacima Software, Inc.

Anju Software

ArisGlobal LLC

Cogstate Ltd.

Cambridge Cognition Ltd.

CliniOps Inc.,

Castor EDC



Adelphi Group

Crucial Data Solutions

For more information about this report visit

About is the world’s leading source for international market research reports and market data. We provide you with the latest data on international and regional markets, key industries, the top companies, new products and the latest trends.


Laura Wood, Senior Press Manager

[email protected]

For E.S.T Office Hours Call 1-917-300-0470

For U.S./ CAN Toll Free Call 1-800-526-8630

For GMT Office Hours Call +353-1-416-8900

Subscribe on LinkedIn

Get the free newsletter

Subscribe to MedicaEx for top news, trends & analysis

We're committed to your privacy. MedicaEx uses the information you provide to us to contact you about our relevant content, products, and services. You may unsubscribe from these communications at any time. For more information, check out our Privacy Policy.

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Businesswire is solely responsible for the content of the above news submissions. If there are any violations of laws, violations of the membership terms of this website, or the risk of infringing on the rights of third parties, businesswire will be solely responsible for legal and damage compensation. Responsibility has nothing to do with MedicaEx.

Are you in?

Subscribe to receive exclusive content and notifications to your inbox

We're committed to your privacy. MedicaEx uses the information you provide to us to contact you about our relevant content, products, and services. You may unsubscribe from these communications at any time. For more information, check out our Privacy Policy.

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.